DE60135665D1 - Neue amidino-derivate und deren verwendung als thrombin-inhibitoren - Google Patents

Neue amidino-derivate und deren verwendung als thrombin-inhibitoren

Info

Publication number
DE60135665D1
DE60135665D1 DE60135665T DE60135665T DE60135665D1 DE 60135665 D1 DE60135665 D1 DE 60135665D1 DE 60135665 T DE60135665 T DE 60135665T DE 60135665 T DE60135665 T DE 60135665T DE 60135665 D1 DE60135665 D1 DE 60135665D1
Authority
DE
Germany
Prior art keywords
thrombin inhibitors
derivatives
amidino derivatives
thrombin
new amidino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60135665T
Other languages
English (en)
Inventor
Tord Inghardt
Arne Svensson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0002921A external-priority patent/SE0002921D0/xx
Priority claimed from SE0002922A external-priority patent/SE0002922D0/xx
Priority claimed from US09/900,903 external-priority patent/US6433186B1/en
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Application granted granted Critical
Publication of DE60135665D1 publication Critical patent/DE60135665D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/54—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DE60135665T 2000-08-16 2001-08-13 Neue amidino-derivate und deren verwendung als thrombin-inhibitoren Expired - Lifetime DE60135665D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE0002921A SE0002921D0 (sv) 2000-08-16 2000-08-16 Pharmaceutically useful compounds
SE0002922A SE0002922D0 (sv) 2000-08-16 2000-08-16 Pharmaceutically useful compounds
US09/900,903 US6433186B1 (en) 2000-08-16 2001-07-10 Amidino derivatives and their use as thormbin inhibitors
PCT/SE2001/001751 WO2002014270A1 (en) 2000-08-16 2001-08-13 New amidino derivatives and their use as thrombin inhibitors

Publications (1)

Publication Number Publication Date
DE60135665D1 true DE60135665D1 (de) 2008-10-16

Family

ID=27354584

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60135665T Expired - Lifetime DE60135665D1 (de) 2000-08-16 2001-08-13 Neue amidino-derivate und deren verwendung als thrombin-inhibitoren

Country Status (18)

Country Link
EP (1) EP1311480B1 (de)
JP (1) JP2004506039A (de)
CN (1) CN1205183C (de)
AT (1) ATE407116T1 (de)
AU (2) AU2001280395B2 (de)
BR (1) BR0113212A (de)
CA (1) CA2415383C (de)
DE (1) DE60135665D1 (de)
DK (1) DK1311480T3 (de)
ES (1) ES2311538T3 (de)
HK (1) HK1053121A1 (de)
IL (1) IL154077A0 (de)
MX (1) MXPA03000643A (de)
NO (1) NO325242B1 (de)
NZ (1) NZ523598A (de)
PT (1) PT1311480E (de)
SI (1) SI1311480T1 (de)
WO (1) WO2002014270A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7129233B2 (en) 2000-12-01 2006-10-31 Astrazeneca Ab Mandelic acid derivatives and their use as thrombin inhibitors
SE0102921D0 (sv) 2001-08-30 2001-08-30 Astrazeneca Ab Pharmaceutically useful compounds
US7018642B2 (en) 2001-04-27 2006-03-28 The Procter & Gamble Company Compounds, compositions, and methods for controlling biofilms
SE0201658D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Immediate release pharmaceutical formulation
SE0201659D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
SE0201661D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab New salts
GB0503672D0 (en) * 2005-02-23 2005-03-30 Astrazeneca Ab New process
EP2512466A4 (de) 2009-12-18 2013-07-03 Activesite Pharmaceuticals Inc Prodrugs von plasmakallikreinhemmern
US9206123B2 (en) 2009-12-18 2015-12-08 Activesite Pharmaceuticals, Inc. Prodrugs of inhibitors of plasma kallikrein
EP2697196A1 (de) 2011-04-13 2014-02-19 Activesite Pharmaceuticals, Inc. Prodrugs von plasmakallikreinhemmern

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA96170106A (ar) * 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
SE9602263D0 (sv) * 1996-06-07 1996-06-07 Astra Ab New amino acid derivatives
WO2000042059A1 (en) * 1999-01-13 2000-07-20 Astrazeneca Ab New amidinobenzylamine derivatives and their use as thrombin inhibitors

Also Published As

Publication number Publication date
AU8039501A (en) 2002-02-25
CA2415383C (en) 2009-11-24
BR0113212A (pt) 2003-07-08
SI1311480T1 (sl) 2008-12-31
AU2001280395B2 (en) 2005-11-24
ES2311538T3 (es) 2009-02-16
EP1311480B1 (de) 2008-09-03
NO20030675L (no) 2003-02-11
NO325242B1 (no) 2008-03-03
HK1053121A1 (en) 2003-10-10
NZ523598A (en) 2004-10-29
EP1311480A1 (de) 2003-05-21
DK1311480T3 (da) 2008-12-01
IL154077A0 (en) 2003-07-31
CN1205183C (zh) 2005-06-08
CA2415383A1 (en) 2002-02-21
MXPA03000643A (es) 2003-06-06
WO2002014270A1 (en) 2002-02-21
PT1311480E (pt) 2008-11-11
JP2004506039A (ja) 2004-02-26
ATE407116T1 (de) 2008-09-15
CN1446199A (zh) 2003-10-01
NO20030675D0 (no) 2003-02-11

Similar Documents

Publication Publication Date Title
SE9602646D0 (sv) Pharmaceutically-useful compounds
SE9602263D0 (sv) New amino acid derivatives
MX9804623A (es) Precursores inactivos de farmacos inhibidores de trombina.
MX9800146A (es) Nuevos inhibidores de trombina, su preparacion y su uso.
CA2294059A1 (en) New amidino derivatives and their use as thrombin inhibitors
CY1107149T1 (el) Νεα παραγωγα αμιδινοβενζυλαμινης και χρηση τους ως αναστολεων θρομβινης
DE60113412D1 (de) Inhibitoren von serin proteasen
EE200000322A (et) Uued ühendid
ATE261939T1 (de) Amidinoderivate und ihre verwendung als thrombin- inhibitoren
SE0001803D0 (sv) New compounds i
ATE407116T1 (de) Neue amidino-derivate und deren verwendung als thrombin-inhibitoren
SE0102921D0 (sv) Pharmaceutically useful compounds
DE60232802D1 (de) Neues mandelsäurederivat und seine verwendung als thrombininhibitor
TWI264434B (en) New mandelic acid derivatives and their use as thrombin inhibitors

Legal Events

Date Code Title Description
8364 No opposition during term of opposition